Molecule Information
General Information of the Molecule (ID: Mol02187)
Name |
HOX transcript antisense RNA (HOTAIR)
,Mus musculus
|
||||
---|---|---|---|---|---|
Synonyms |
Hotair
Click to Show/Hide
|
||||
Molecule Type |
LncRNA
|
||||
Gene Name |
Hotair
|
||||
Gene ID | |||||
Location |
chr15:102,852,494-102,856,165[-]
|
||||
Ensembl ID | |||||
Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
EADR: Epigenetic Alteration of DNA, RNA or Protein
Drug Resistance Data Categorized by Drug
Approved Drug(s)
2 drug(s) in total
Andrographolide
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Epigenetic Alteration of DNA, RNA or Protein (EADR) | ||||
Disease Class: Chronic obstructive pulmonary disease | [1] | |||
Resistant Disease | Chronic obstructive pulmonary disease [ICD-11: CA22.0] | |||
Resistant Drug | Andrographolide | |||
Molecule Alteration | Up-regulation | Expression |
||
Experimental Note | Revealed Based on the Cell Line Data | |||
In Vitro Model | SV40 cells | N.A. | . | N.A. |
In Vivo Model | Male BALB/c mice moddel | Mus musculus | ||
Mechanism Description | Andrographolide antagonizes the cigarette smoke-induced epithelial-mesenchymal transition and pulmonary dysfunction through anti-inflammatory inhibiting HOTAIR. | |||
Disease Class: Pulmonary dysfunction | [1] | |||
Resistant Disease | Pulmonary dysfunction [ICD-11:BB01.1] | |||
Resistant Drug | Andrographolide | |||
Molecule Alteration | Up-regulation | Expression |
||
Experimental Note | Discovered Using In-vivo Testing Model | |||
In Vitro Model | HBECs | Bronchus | Homo sapiens (Human) | CVCL_0287 |
In Vivo Model | Male BALB/c mice CS-exposed model | Mus musculus | ||
Experiment for Drug Resistance |
Annexin V-PI Apoptosis detection; Flow cytometry assay | |||
Mechanism Description | Andrographolide antagonizes the cigarette smoke-induced epithelial-mesenchymal transition and pulmonary dysfunction through anti-inflammatory inhibiting HOTAIR. |
Silicon dioxide
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Epigenetic Alteration of DNA, RNA or Protein (EADR) | ||||
Disease Class: Silicosis | [1] | |||
Resistant Disease | Silicosis [ICD-11: CA60.0Z] | |||
Resistant Drug | Silicon dioxide | |||
Molecule Alteration | Up-regulation | Interaction |
||
Experimental Note | Discovered Using In-vivo Testing Model | |||
In Vitro Model | A549 cells | Lung | Homo sapiens (Human) | CVCL_0023 |
MRC-5 cells | Lung | Homo sapiens (Human) | CVCL_0440 | |
NIH/3T3 cells | Whole embryo | Mus musculus (Mouse) | CVCL_0594 | |
HBE cells | Bronchus | Homo sapiens (Human) | CVCL_0287 | |
In Vivo Model | Silica-Induced lung Fibrosis mouse model; Lung Fibrosis MiR-326 overexpression mouse model | Mus musculus | ||
Experiment for Molecule Alteration |
Western bloting analysis; Immunofluorescence assay; Knockdown assay | |||
Experiment for Drug Resistance |
Dual luciferase reporter assays | |||
Mechanism Description | miR-326 Inhibits Inflammation and Promotes Autophagy in Silica-Induced Pulmonary Fibrosis through Targeting TNFSF14 and PTBP1. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.